Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) insider Scott Bohn sold 10,989 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
Healthpeak Properties Price Performance
DOC stock opened at $19.56 on Thursday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The firm has a 50 day moving average price of $17.19 and a 200-day moving average price of $17.19. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $19.87. The firm has a market capitalization of $13.48 billion, a price-to-earnings ratio of 61.11, a PEG ratio of 2.73 and a beta of 1.00.
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the company earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities research analysts forecast that Healthpeak Properties, Inc. will post 1.74 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
Analyst Upgrades and Downgrades
DOC has been the topic of several recent analyst reports. Scotiabank raised shares of Healthpeak Properties to a “hold” rating in a research report on Thursday, April 23rd. Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Robert W. Baird upped their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research note on Wednesday. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday. Finally, Citigroup upped their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday. Four equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $18.75.
Check Out Our Latest Report on DOC
Institutional Trading of Healthpeak Properties
Large investors have recently added to or reduced their stakes in the business. Argent Advisors Inc. acquired a new stake in shares of Healthpeak Properties during the third quarter worth $1,536,000. Twin City Private Wealth LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $1,148,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Healthpeak Properties by 7.0% in the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,935,397 shares of the real estate investment trust’s stock worth $37,063,000 after acquiring an additional 126,322 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Healthpeak Properties by 8.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 6,754,147 shares of the real estate investment trust’s stock worth $129,342,000 after acquiring an additional 525,875 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
